The Oncogenic STP Axis Promotes Triple-Negative Breast Cancer via Degradation of the REST Tumor Suppressor

Kristen L. Karlin, Gourish Mondal, Jessica K. Hartman, Siddhartha Tyagi, Sarah J. Kurley, Chris S. Bland, Tiffany Y T Hsu, Alexander Renwick, Justin E. Fang, Ilenia Migliaccio, Celetta Callaway, Amritha Nair, Rocio Dominguez-Vidana, Don X. Nguyen, C. Kent Osborne, Rachel Schiff, Li Yuan Yu-Lee, Sung Y. Jung, Dean P. Edwards, Susan G. Hilsenbeck & 5 others Jeffrey M. Rosen, Xiang H F Zhang, Chad A. Shaw, Fergus J Couch, Thomas F. Westbrook

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Defining the molecular networks that drive breast cancer has led to therapeutic interventions and improved patient survival. However, the aggressive triple-negative breast cancer subtype (TNBC) remains recalcitrant to targeted therapies because its molecular etiology is poorly defined. In this study, we used a forward genetic screen to discover an oncogenic network driving human TNBC. SCYL1, TEX14, and PLK1 ("STP axis") cooperatively trigger degradation of the REST tumor suppressor protein, a frequent event in human TNBC. The STP axis induces REST degradation by phosphorylating a conserved REST phospho-degron and bridging REST interaction with the ubiquitin-ligase βTRCP. Inhibition of the STP axis leads to increased REST protein levels and impairs TNBC transformation, tumor progression, and metastasis. Expression of the STP axis correlates with low REST protein levels in human TNBCs and poor clinical outcome for TNBC patients. Our findings demonstrate that the STP-REST axis is a molecular driver of human TNBC.

Original languageEnglish (US)
Pages (from-to)1318-1332
Number of pages15
JournalCell Reports
Volume9
Issue number4
DOIs
StatePublished - Nov 20 2014

Fingerprint

Triple Negative Breast Neoplasms
Tumors
Tumor Suppressor Proteins
Degradation
Ligases
Ubiquitin
Neoplasms
Proteins
Breast Neoplasms
Neoplasm Metastasis
Survival
Therapeutics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Karlin, K. L., Mondal, G., Hartman, J. K., Tyagi, S., Kurley, S. J., Bland, C. S., ... Westbrook, T. F. (2014). The Oncogenic STP Axis Promotes Triple-Negative Breast Cancer via Degradation of the REST Tumor Suppressor. Cell Reports, 9(4), 1318-1332. https://doi.org/10.1016/j.celrep.2014.10.011

The Oncogenic STP Axis Promotes Triple-Negative Breast Cancer via Degradation of the REST Tumor Suppressor. / Karlin, Kristen L.; Mondal, Gourish; Hartman, Jessica K.; Tyagi, Siddhartha; Kurley, Sarah J.; Bland, Chris S.; Hsu, Tiffany Y T; Renwick, Alexander; Fang, Justin E.; Migliaccio, Ilenia; Callaway, Celetta; Nair, Amritha; Dominguez-Vidana, Rocio; Nguyen, Don X.; Osborne, C. Kent; Schiff, Rachel; Yu-Lee, Li Yuan; Jung, Sung Y.; Edwards, Dean P.; Hilsenbeck, Susan G.; Rosen, Jeffrey M.; Zhang, Xiang H F; Shaw, Chad A.; Couch, Fergus J; Westbrook, Thomas F.

In: Cell Reports, Vol. 9, No. 4, 20.11.2014, p. 1318-1332.

Research output: Contribution to journalArticle

Karlin, KL, Mondal, G, Hartman, JK, Tyagi, S, Kurley, SJ, Bland, CS, Hsu, TYT, Renwick, A, Fang, JE, Migliaccio, I, Callaway, C, Nair, A, Dominguez-Vidana, R, Nguyen, DX, Osborne, CK, Schiff, R, Yu-Lee, LY, Jung, SY, Edwards, DP, Hilsenbeck, SG, Rosen, JM, Zhang, XHF, Shaw, CA, Couch, FJ & Westbrook, TF 2014, 'The Oncogenic STP Axis Promotes Triple-Negative Breast Cancer via Degradation of the REST Tumor Suppressor', Cell Reports, vol. 9, no. 4, pp. 1318-1332. https://doi.org/10.1016/j.celrep.2014.10.011
Karlin, Kristen L. ; Mondal, Gourish ; Hartman, Jessica K. ; Tyagi, Siddhartha ; Kurley, Sarah J. ; Bland, Chris S. ; Hsu, Tiffany Y T ; Renwick, Alexander ; Fang, Justin E. ; Migliaccio, Ilenia ; Callaway, Celetta ; Nair, Amritha ; Dominguez-Vidana, Rocio ; Nguyen, Don X. ; Osborne, C. Kent ; Schiff, Rachel ; Yu-Lee, Li Yuan ; Jung, Sung Y. ; Edwards, Dean P. ; Hilsenbeck, Susan G. ; Rosen, Jeffrey M. ; Zhang, Xiang H F ; Shaw, Chad A. ; Couch, Fergus J ; Westbrook, Thomas F. / The Oncogenic STP Axis Promotes Triple-Negative Breast Cancer via Degradation of the REST Tumor Suppressor. In: Cell Reports. 2014 ; Vol. 9, No. 4. pp. 1318-1332.
@article{6c77dd92cd434132ba2df417e4008a1a,
title = "The Oncogenic STP Axis Promotes Triple-Negative Breast Cancer via Degradation of the REST Tumor Suppressor",
abstract = "Defining the molecular networks that drive breast cancer has led to therapeutic interventions and improved patient survival. However, the aggressive triple-negative breast cancer subtype (TNBC) remains recalcitrant to targeted therapies because its molecular etiology is poorly defined. In this study, we used a forward genetic screen to discover an oncogenic network driving human TNBC. SCYL1, TEX14, and PLK1 ({"}STP axis{"}) cooperatively trigger degradation of the REST tumor suppressor protein, a frequent event in human TNBC. The STP axis induces REST degradation by phosphorylating a conserved REST phospho-degron and bridging REST interaction with the ubiquitin-ligase βTRCP. Inhibition of the STP axis leads to increased REST protein levels and impairs TNBC transformation, tumor progression, and metastasis. Expression of the STP axis correlates with low REST protein levels in human TNBCs and poor clinical outcome for TNBC patients. Our findings demonstrate that the STP-REST axis is a molecular driver of human TNBC.",
author = "Karlin, {Kristen L.} and Gourish Mondal and Hartman, {Jessica K.} and Siddhartha Tyagi and Kurley, {Sarah J.} and Bland, {Chris S.} and Hsu, {Tiffany Y T} and Alexander Renwick and Fang, {Justin E.} and Ilenia Migliaccio and Celetta Callaway and Amritha Nair and Rocio Dominguez-Vidana and Nguyen, {Don X.} and Osborne, {C. Kent} and Rachel Schiff and Yu-Lee, {Li Yuan} and Jung, {Sung Y.} and Edwards, {Dean P.} and Hilsenbeck, {Susan G.} and Rosen, {Jeffrey M.} and Zhang, {Xiang H F} and Shaw, {Chad A.} and Couch, {Fergus J} and Westbrook, {Thomas F.}",
year = "2014",
month = "11",
day = "20",
doi = "10.1016/j.celrep.2014.10.011",
language = "English (US)",
volume = "9",
pages = "1318--1332",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - The Oncogenic STP Axis Promotes Triple-Negative Breast Cancer via Degradation of the REST Tumor Suppressor

AU - Karlin, Kristen L.

AU - Mondal, Gourish

AU - Hartman, Jessica K.

AU - Tyagi, Siddhartha

AU - Kurley, Sarah J.

AU - Bland, Chris S.

AU - Hsu, Tiffany Y T

AU - Renwick, Alexander

AU - Fang, Justin E.

AU - Migliaccio, Ilenia

AU - Callaway, Celetta

AU - Nair, Amritha

AU - Dominguez-Vidana, Rocio

AU - Nguyen, Don X.

AU - Osborne, C. Kent

AU - Schiff, Rachel

AU - Yu-Lee, Li Yuan

AU - Jung, Sung Y.

AU - Edwards, Dean P.

AU - Hilsenbeck, Susan G.

AU - Rosen, Jeffrey M.

AU - Zhang, Xiang H F

AU - Shaw, Chad A.

AU - Couch, Fergus J

AU - Westbrook, Thomas F.

PY - 2014/11/20

Y1 - 2014/11/20

N2 - Defining the molecular networks that drive breast cancer has led to therapeutic interventions and improved patient survival. However, the aggressive triple-negative breast cancer subtype (TNBC) remains recalcitrant to targeted therapies because its molecular etiology is poorly defined. In this study, we used a forward genetic screen to discover an oncogenic network driving human TNBC. SCYL1, TEX14, and PLK1 ("STP axis") cooperatively trigger degradation of the REST tumor suppressor protein, a frequent event in human TNBC. The STP axis induces REST degradation by phosphorylating a conserved REST phospho-degron and bridging REST interaction with the ubiquitin-ligase βTRCP. Inhibition of the STP axis leads to increased REST protein levels and impairs TNBC transformation, tumor progression, and metastasis. Expression of the STP axis correlates with low REST protein levels in human TNBCs and poor clinical outcome for TNBC patients. Our findings demonstrate that the STP-REST axis is a molecular driver of human TNBC.

AB - Defining the molecular networks that drive breast cancer has led to therapeutic interventions and improved patient survival. However, the aggressive triple-negative breast cancer subtype (TNBC) remains recalcitrant to targeted therapies because its molecular etiology is poorly defined. In this study, we used a forward genetic screen to discover an oncogenic network driving human TNBC. SCYL1, TEX14, and PLK1 ("STP axis") cooperatively trigger degradation of the REST tumor suppressor protein, a frequent event in human TNBC. The STP axis induces REST degradation by phosphorylating a conserved REST phospho-degron and bridging REST interaction with the ubiquitin-ligase βTRCP. Inhibition of the STP axis leads to increased REST protein levels and impairs TNBC transformation, tumor progression, and metastasis. Expression of the STP axis correlates with low REST protein levels in human TNBCs and poor clinical outcome for TNBC patients. Our findings demonstrate that the STP-REST axis is a molecular driver of human TNBC.

UR - http://www.scopus.com/inward/record.url?scp=84912118947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912118947&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2014.10.011

DO - 10.1016/j.celrep.2014.10.011

M3 - Article

VL - 9

SP - 1318

EP - 1332

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 4

ER -